Contact Us    Downloads    Login  
   

              
 

Case Studies


Microdose Technologies

  • Sage invested over $200,000 in MicroDose at $1 per share as part of a financing in excess of $750,000 arranged by Sage.
  • Sage assisted in negotiating a $30 million marketing partnership with BMS for a joint venture of MicroDose
  • Sage assisted in raising $1.5 million in financing for a subsidiary of MicroDose at $2 per share
  • As a result of the BMS transaction, 3M invested $5 million in MicroDose at $3.50 per share, in a deal assisted by Sage
  • Subsequently, Sage assisted MicroDose in a $125 million multiproduct development deal with Novartis
     

 Return to all case studies




Tel-Aviv, Israel, March 27, 2013 - Sage's client RedHill Biopharma Ltd. (NASDAQ: RDHL; TASE: RDHL) (the “Company” or “RedHill”), an emerging Israeli biopharmaceutical company focused primar...Read entire article




The Sage Group is pleased to announce that Wayne Pambianchi, Executive Director, gave an invited lecture to entrepreneurs at a European conference in Warsaw in February 2013. The video can be viewed on YouTube using the link belo...Read entire article




Barcelona, Spain – Feb 2013 – The Sage Group (www.sagehealthcare.com)  is pleased to announce its appointment by Palau Pharma S.A. as advisors to develop strategic corporat...Read entire article

Contact Us


If you are interested in contacting us or obtaining the contact details for one of our offices, please use our contact page.

If you would like to make a more comprehensive business enquiry, you can send us further details of your company using our Business Enquiry Form.


© The Sage Group 2008 Site by YouSoft   Privacy Policy   Contact us